General
- For catch-up, use single dose of 9v vaccine (base case: no catch-up)
- GAVI is covering catch-up for some GAVI eligible countries
- 90% vaccine efficacy to account for oncongenic HPV types not covered by vaccine
- More clearance than immunity
- Low screening coverage (~9%)
- Weighted average vaccine immunity according to expected vaccine dose uptake rates and corresponding efficacy

Questions
- What is coverage for family planning and ANC in KZN?

Sensitivity Analyses:
- Natural immunity
- Vaccine efficacy (70 - 100)
- Vaccine coverage 
- Scale-up period (3, 5 years)
- Vaccine provision (for 10, 15, 20 years from current year)


